Dover has entered right into a definitive settlement to amass Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and control devices for the biopharmaceutical, semiconductor and industrial sectors.
เกจวัดแรงดันน้ำราคา will broaden Dover’s biopharma single-use production providing, which already consists of Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with amenities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in revenue during the full 12 months 2022.
When the deal closes, Malema will turn out to be a half of the PSG business unit within Dover’s Pumps & Process Solutions segment.
“We see an amazing long-term progress opportunity in the bioprocessing industry driven by a powerful and growing pipeline of efficient novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, as nicely as budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more environment friendly single-use production processes supports a robust outlook for our choices of single-use parts to end-customers. We consider that pairing Malema’s know-how with our present portfolio of single-use pumps for biopharma processing will significantly improve the accuracy and worth proposition of our options to our customers.”
“We are methodically constructing out our biopharma platform via proactive capability additions, new product growth, and opportunistic acquisitions of highly-attractive area of interest element technologies,” mentioned Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing know-how and additional strengthens our sensor portfolio with new proprietary technology. In addition to engaging biopharma purposes, we count on strong development in the semiconductor space on the capacity growth and re-shoring tailwinds.”
Share